Kyle Stults

Kyle Stults joined Novus Via in July 2012 and is responsible for investor relations and portfolio company strategy and execution.
From 2005 until 2011, Kyle was the Director of Investor Relations and Corporate Development at Martek Biosciences (formerly NASDAQ: MATK), a leader in the innovation and production of high-value products from microbial sources that promote health and wellness through nutrition.
Prior to joining Martek, Kyle was engaged in the financial sector for over six years, including being an Equity Research Analyst with Wm Smith & Company, a special situations equity research boutique based in Denver, CO, and prior to that, as an Analyst at SG Cowen Securities Corporation, a global investment bank focused on the technology and healthcare sectors.
During his tenure at SG Cowen in Boston and New York, Mr. Stults was part of the mergers and acquisitions (M&A) advisory team and was directly involved in the completion of numerous public and private transactions ranging in size from $25 million to $1 billion.
Mr. Stults is a native of Wray, Colorado, and a graduate of the University of Denver’s Daniels College of Business where he graduated cum laude with a B.S.
in Business Administration with an emphasis in Finance.